My father is a 72-year-old who suffers from idiopathic pulmonary fibrosis (IPF). It’s a lung disease with no cure with a bleak prognosis resulting in death 3 to 5 years of diagnosis. In April, this year, dad had an exacerbation after an attempt to treat with stem cell therapy. Stem cell therapy is not FDA-approved or monitored and there are some providers making a lot of cash off vulnerab ...[Show More]
Published: 3 years ago
Published By: Chelsea Kim
University of Kabianga > Essay > Idiopathic pulmonary fibrosis and stem cell therapy risk page(s)
Purchase the document to unlock it.
This paper costs $ 4
You may use credit points to purchase the paper. Register below to earn 25 credits. Register Here >>
Category: | Essay |
Published By: | Chelsea Kim |
Published On: | 3 years ago |
Number of pages: | 8 |
Language: | English |
You may use credit points to purchase the paper. Register below to earn 25 credits. Register Here >>